Companies / Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc.
CNCECIK 1367920
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Aldrich Richard Director | Buy Open-market buy | Common Stock | $1000.0K | +211K | 210,526 | high |
| Mar 11, 2015 | Stuart Nancy Executive | Sell Open-market sale | Common Stock | $696.5K | -46K -82.28% | 10,000 | medium |
| Mar 10, 2015 | McGowan Pauline Executive | Sell Open-market sale | Common Stock | $123.0K | -9K -100.00% | 0 | medium |
| Jan 30, 2023 | Stuart Nancy Executive | Sell Open-market sale | Common Stock | $110.2K | -13K -4.68% | 268,644 | medium |
| Mar 10, 2015 | McGowan Pauline Executive | Sell Open-market sale | Common Stock | $98.4K | -7K -100.00% | 0 | low |
| Feb 17, 2021 | Tung Roger D CEO | Sell Open-market sale | Common Stock | $97.1K | -13K -1.64% | 808,578 | low |
| Mar 11, 2015 | McGowan Pauline Executive | Sell Open-market sale | Common Stock | $95.6K | -6K -100.00% | 0 | low |
| Mar 10, 2015 | McGowan Pauline Executive | Sell Open-market sale | Common Stock | $86.1K | -6K -100.00% | 0 | low |